(Reuters) – A panel of Indian specialists is investigating if there are any home instances of blood clotting, even delicate ones, as a aspect impact of the 2 COVID-19 vaccines being administered within the nation, monetary each day Mint reported on Friday.
India is at present administering AstraZeneca’s COVID-19 vaccine and a shot developed at residence by Bharat Biotech. (https://bit.ly/2OAP4wc)
A number of international locations in Europe have introduced restrictions on using the AstraZeneca vaccine in youthful individuals, after a hyperlink was discovered to very uncommon blood clots, largely in ladies beneath 60 years of age inside two weeks of vaccination.
(Reporting by Juby Babu in Bengaluru; Modifying by Shounak Dasgupta)
Copyright 2021 Thomson Reuters.